30 septiembre 2015
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research.
http://www.sciencedaily.com/releases/2015/09/150930140621.htm
